ArticleMedicine2025
Association of metabolic disorders and lifestyle behaviors with epilepsy: Evidence from the NHANES database.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of metformin for epilepsy prevention or seizure control in people without evidence of diabetes: retrospective cohort study.Journal of neurology, neurosurgery, and psychiatry · 2026Article
- Insulin Resistance as a Shared Pathophysiological Driver in Neurological Disorders: a Narrative Review.Current nutrition reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epilepsy is a common neurological disorder that places a substantial burden on healthcare systems worldwide. Identifying associated risk factors is essential for effective prevention and management. This study examined the associations between epilepsy and key metabolic disorders (diabetes, hypertension) together with modifiable lifestyle factors (body mass index [BMI], smoking, alcohol consumption) using nationally representative NHANES data. We analyzed publicly available data from the 2017-2018 cycle of NHANES, including 9254 eligible participants. Key covariates, such as age, sex, BMI, history of diabetes, hypertension, smoking, and alcohol use, were collected. Both univariate and multivariable logistic regressions were performed to evaluate associations. The predictive performance of logistic regression and random forest models for epilepsy was assessed using receiver operating characteristic curves. Significant differences in age, education level, BMI, cardiometabolic indicators, and lifestyle behaviors were observed between individuals with and without epilepsy (P < .001). In multivariable analyses, older age (adjusted odds ratio [aOR] = 2.42, 95% confidence interval [CI]: 2.33-2.50), obesity (aOR = 1.65, 95% CI: 1.73-2.09), diabetes (aOR = 2.48, 95% CI: 2.23-2.75), and smoking (current smoking aOR = 1.90, 95% CI: 1.73-2.09; former smoking aOR = 1.50, 95% CI: 1.38-1.64) were independently associated with higher epilepsy risk. Hypertension showed an inverse association (aOR = 0.83, 95% CI: 0.75-0.91). Alcohol consumption did not remain a significant independent predictor after adjustment. Older age, obesity, diabetes, and smoking were independent risk factors for epilepsy, whereas hypertension showed an inverse association. These findings underscore the importance of targeted prevention strategies, risk stratification, and early intervention in populations at risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.